Search results
Results from the WOW.Com Content Network
Misclassification under the Medicaid Drug Rebate Program: EpiPen (epinephrine) False Claims Act: 2006 Schering-Plough [21] $435 million Off-label promotion, kickbacks, Medicare fraud Temodar, Intron A, K-Dur, Claritin RediTabs: False Claims Act, FDCA 2004 [22] Pfizer $430 million Off-label promotion Neurontin: False Claims Act, FDCA 2008 ...
Bank of America took a hit owing to its 2008 acquisition of Merrill Lynch in 2013, when Merrill Lynch agreed to pay $160 million to settle a class-action racial discrimination lawsuit brought by a ...
Kaplan, Inc.#Class-action lawsuit; Keele Valley Landfill#Resident class action lawsuit; Kemper Corporation#Class-action lawsuit; Kids for cash scandal#Victim lawsuits; Kweku Hanson#Class action lawsuit against Ocwen Federal FSB; Lead contamination in Washington, D.C. drinking water#Class-action lawsuit; Long-term effects of benzodiazepines# ...
Facebook recently paid 1.4 million Illinois residents $397 in 2022 as part of a class action lawsuit for facial recognition breaches through its “Tag Suggestions” feature, per CNBC.
The Los Angeles Times headlined "Public Faces Overdose of Similar Drug Names." [14] The market for Zantac [15] and its competitors was described in 2005 as 13.5 billion US dollars. [16] The product's problem was described by The New York Times as being "that a potential cancer-causing contaminant can build up in the drug when stored for long ...
The newly unsealed complaint in Providence, Rhode Island federal court alleges that, from October 2013 to the present, CVS violated the federal Controlled Substances Act by filling prescriptions ...
Cuneiform tablet case for record of a lawsuit ca. 20th–19th century B.C. Lists of lawsuits cover various types of lawsuits . They are organized by topics and fields, and by individual companies or people.
The industry is anxiously awaiting the Sept. 1 release of the first 10 drugs the Centers for Medicare and Medicaid Services (CMS) will target for new negotiated prices.